Timothy Fry’s Post

Discover the keys to successful private equity transactions in healthcare with insights from MedEconomics. Dive into this article by Bert Orlov, Managing Director in EisnerAmper's Health Care Industry Group. https://okt.to/gTPYAu

Discover the keys to successful private equity transactions in healthcare with insights from MedEconomics. Dive into this article by Bert Orlov, Managing Director in EisnerAmper's Health Care Industry Group. https://okt.to/FwSXU3

Discover the keys to successful private equity transactions in healthcare with insights from MedEconomics. Dive into this article by Bert Orlov, Managing Director in EisnerAmper's Health Care Industry Group. https://okt.to/6U7SHF

With a new administration in Washington, an increasing number of M&A transactions in process and expected, and rapidly evolving technology solutions for how care is given and supported, 2025 is shaping up to be quite a transformative year for the health care and life science sector. CLA (CliftonLarsonAllen)'s latest white paper from Jennifer Boese, MS takes a look at what we see as the 4 key industry drivers for 2024, as well as what to expect in each of the individual industry sectors - check it out!

Eveline Van Keymeulen, Global Vice Chair of Latham’s Healthcare & Life Sciences Practice and Industry Group, shares that upcoming regulatory and policy changes are top of mind for investors and companies on both sides of the Atlantic at the J.P. Morgan Healthcare Conference. https://lw.link/qkp6VF #jpm2025

Eveline Van Keymeulen, Global Vice Chair of Latham’s Healthcare & Life Sciences Practice and Industry Group, shares that upcoming regulatory and policy changes are top of mind for investors and companies on both sides of the Atlantic at the J.P. Morgan Healthcare Conference. https://lw.link/hTzBqa #jpm2025

PitchBook's McGuireWoods LLP HCPE conference recap is out. Read the full report here: https://lnkd.in/g5eYAHXu >> More market activity is not yet translating into deal announcements. Processes are still long and halting. While the market is still waiting for the Fed to start cutting rates, sellers may bite the bullet and take a lower multiple if we continue to get "higher for longer" signals. >> As the BSL market reopens, the financing environment is becoming slightly more buyer friendly, especially in the upper half of the market. Dual processes are becoming more common. EBITDA and interest coverage remain the key areas of lender scrutiny. >> The antitrust environment is taking up a lot of mind share. >> PPMs have fallen so severely out of fashion that the current period was compared to the 1990s—an overstatement, but indicative of the market’s sentiment. >> Physician compensation is becoming even more challenging than usual as elongated holding times and margin compression erode the value of the “second bite.” >> Medspa is still hot, and we expect forward-thinking firms to increasingly integrate medspa with other women's health and wellness components such as concierge, HRT, weight loss >> Pharma services, especially trial sites, looks very competitive for this year

Eveline Van Keymeulen, Global Vice Chair of Latham’s Healthcare & Life Sciences Practice and Industry Group, shares that upcoming regulatory and policy changes are top of mind for investors and companies on both sides of the Atlantic at the J.P. Morgan Healthcare Conference. https://lw.link/cJ7x86 #jpm2025

# Only put off until tomorrow what you are willing to die having left undone ## Seize the opportunity and invest in healthcare: Pediatrix Medical Group Q2 Earnings Snapshot 🏥💰 In the latest earnings snapshot, Pediatrix Medical Group has demonstrated impressive growth, highlighting the immense potential of investing in the healthcare sector. With a focus on providing medical services to families, this company presents a unique opportunity for investors looking to grow their Health Savings Account \(HSA\) while contributing to the well-being of others. Pediatrix Medical Group's second-quarter earnings showcase a remarkable performance, reflecting their commitment to delivering quality healthcare solutions. As an experienced Investment Advisor, I encourage you to consider this investment avenue to further maximize the potential of your HSA. By acting now, you can avoid the Fear of Missing Out \(FOMO\) and take advantage of the upward trajectory of Pediatrix Medical Group. Investing in the healthcare industry not only aligns with your financial goals but also allows you to contribute to the betterment of society, improving the overall health and wellness of families. Don't miss out on this exceptional opportunity! Take action today and let your HSA flourish by investing in Pediatrix Medical Group. Together, we can create a brighter future for both your financial prosperity and the well-being of individuals and their loved ones. 📈💪 #hsa #investing #healthcare #health #family #wellness 💼🌡️👨👩👧👦💚🌟